We used siRNA to knock down the expressions of SH3BGRL2 in HCCC‐9810 and QBC‐939 cell lines to confirm the association between the decreased SH3BGRL2 and the improved OS for patients with CCA. This evidence concerns the gene SH3BGRL2 and cholangiocarcinoma.